Patients with diabetes taking a semaglutide medication face a higher risk of NAION, a potentially debilitating ophthalmic condition. Semaglutide medication use is linked with a greater risk of ...
The development of ocular signs of neurofibromatosis type 1 (NF1) is only significant in patients 7 years of age and younger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback